Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H21N3O2S.C4H6O4 |
Molecular Weight | 413.488 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CCC(O)=O.CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1
InChI
InChIKey=PORMUFZNYQJOEI-UHFFFAOYSA-N
InChI=1S/C14H21N3O2S.C4H6O4/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3;5-3(6)1-2-4(7)8/h4-5,8-9,15-16H,6-7,10H2,1-3H3;1-2H2,(H,5,6)(H,7,8)
Molecular Formula | C4H6O4 |
Molecular Weight | 118.088 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C14H21N3O2S |
Molecular Weight | 295.4 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:12:39 UTC 2023
by
admin
on
Fri Dec 15 15:12:39 UTC 2023
|
Record UNII |
J8BDZ68989
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47794
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
SUMATRIPTAN GALPHARM (REFUSED: MIGRAINE DISORDERS)
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DBSALT001003
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
67158
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | RxNorm | ||
|
59772
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
DTXSID60145966
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
SUB15437MIG
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
100000077527
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
1642201
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
AA-44
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
J8BDZ68989
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
J8BDZ68989
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
C29470
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
103628-48-4
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
m10396
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | Merck Index | ||
|
64359
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
760362
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY | |||
|
CHEMBL128
Created by
admin on Fri Dec 15 15:12:39 UTC 2023 , Edited by admin on Fri Dec 15 15:12:39 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
Calculate the percentage of sumatriptan related compound A free base in the portion of sumatriptan free base taken
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.6
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |